262 related articles for article (PubMed ID: 2671477)
1. [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
Brunkhorst R; Wrenger E; Kühn K; Schmidt FW; Koch K
Klin Wochenschr; 1989 Aug; 67(15):774-83. PubMed ID: 2671477
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
van Vliet AA; Hackeng WH; Donker AJ; Meuwissen SG
J Hepatol; 1992 May; 15(1-2):40-7. PubMed ID: 1324274
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
Pérez-Ayuso RM; Arroyo V; Planas R; Gaya J; Bory F; Rimola A; Rivera F; Rodés J
Gastroenterology; 1983 May; 84(5 Pt 1):961-8. PubMed ID: 6339312
[TBL] [Abstract][Full Text] [Related]
5. Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion.
Knauf H; Wenk E; Schölmerich J; Goerg KJ; Gerok W; Leser HG; Mutschler E
Klin Wochenschr; 1990 Jun; 68(11):545-51. PubMed ID: 2198378
[TBL] [Abstract][Full Text] [Related]
6. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV
J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107
[TBL] [Abstract][Full Text] [Related]
7. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
[TBL] [Abstract][Full Text] [Related]
8. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
Arroyo V; Bosch J; Casamitjana R; Cabrera J; Rivera F; Rodés J
Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
[TBL] [Abstract][Full Text] [Related]
9. Liver cirrhosis with ascites: pathogenesis of resistance to diuretics and long-term efficacy and safety of torasemide.
Knauf H; Mutschler E
Cardiology; 1994; 84 Suppl 2():87-98. PubMed ID: 7954550
[TBL] [Abstract][Full Text] [Related]
10. Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.
Thomsen OO; Danielsen H; Sørensen SS; Pedersen EB
Eur J Clin Pharmacol; 1986; 30(1):1-6. PubMed ID: 3519238
[TBL] [Abstract][Full Text] [Related]
11. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
Leehey DJ; Gollapudi P; Deakin A; Reid RW
J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
[TBL] [Abstract][Full Text] [Related]
12. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.
Thiesson HC; Jensen BL; Jespersen B; Schaffalitzky de Muckadell OB; Bistrup C; Walter S; Ottosen PD; Veje A; Skøtt O
Am J Physiol Renal Physiol; 2005 May; 288(5):F1044-52. PubMed ID: 15613622
[TBL] [Abstract][Full Text] [Related]
14. Effects of captopril on renal function in patients with cirrhosis and ascites.
Daskalopoulos G; Pinzani M; Murray N; Hirschberg R; Zipser RD
J Hepatol; 1987 Jun; 4(3):330-6. PubMed ID: 3298415
[TBL] [Abstract][Full Text] [Related]
15. Enhanced renin levels after discontinuation of furosemide: additional effects of loop diuretics on renin release.
Tuck ML; Sambhi MP; Kramer SB; Eggena P; Barrett J
Clin Exp Hypertens A; 1982; 4(8):1359-75. PubMed ID: 6749346
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with IVCS and gross oedema and ascites with diuretic combination and ACE-inhibitors: relation to baseline PRA and PAC.
Van Vliet AA; Kröger R; Dubbelman R; Ten Bokkel-Huinink WW
Neth J Med; 1995 Feb; 46(2):62-72. PubMed ID: 7885524
[TBL] [Abstract][Full Text] [Related]
17. Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.
Hanafy AS; Hassaneen AM
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1455-1461. PubMed ID: 27622998
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemide.
Bernardi M; De Palma R; Trevisani F; Santini C; Patrono D; Motta R; Servadei D; Gasbarrini G
Hepatology; 1986; 6(3):400-5. PubMed ID: 3519416
[TBL] [Abstract][Full Text] [Related]
19. Changes in glomerular filtration rate and renal plasma flow in cirrhotic rats during converting enzyme inhibition.
Ibarra FR; Galcerán T; Oddo E; Arrizurieta E
Ren Fail; 1998 Jan; 20(1):65-74. PubMed ID: 9509561
[TBL] [Abstract][Full Text] [Related]
20. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.
Yang YY; Lin HC; Lin MW; Chu CJ; Lee FY; Hou MC; Lee SD; Lee WP; Liu TT; Jap TS
Clin Sci (Lond); 2011 Dec; 121(11):509-21. PubMed ID: 21692745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
